Rochester Medical Corp (ROCM) Misses Q1 EPS by 1c, Sales Fall Short
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts ROCM Hot Sheet
Join SI Premium – FREE
Rochester Medical Corp (NASDAQ: ROCM) reported Q1 non-GAAP EPS of $0.02, $0.01 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $13.85 million versus the consensus estimate of $14.9 million.
For earnings history and earnings-related data on Rochester Medical Corp (ROCM) click here.
For earnings history and earnings-related data on Rochester Medical Corp (ROCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Some Said Inflation Risks Had Become More Skewed To Upside - FOMC Minutes
- FDA approves Pfizer's Tukysa as front-line maintenance for HER2+ breast cancer
- Hess Midstream stock drops on Chevron restructuring and lower 2027 outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
